- Home
- SDST vs ABVC Comparison
SDST vs ABVC Comparison
Compare SDST & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDST | ABVC |
|---|---|---|
| Founded | 2022 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.9M | 50.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SDST | ABVC |
|---|---|---|
| Price | $4.52 | $2.04 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 920.2K | 55.6K |
| Earning Date | 11-13-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $797,916.00 |
| Revenue This Year | N/A | $735.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 56.52 |
| 52 Week Low | $1.43 | $0.40 |
| 52 Week High | $13.70 | $5.48 |
Technical Indicators
Market Signals| Indicator | SDST | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 65.02 | 40.96 |
| Support Level | $4.10 | $2.00 |
| Resistance Level | $4.87 | $2.20 |
| Average True Range (ATR) | 0.45 | 0.12 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 76.39 | 22.86 |
Price Performance
Historical ComparisonAbout SDST Stardust Power Inc.
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.